ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "dermatomyositis"

  • Abstract Number: 1175 • ACR Convergence 2023

    Inclusion of All Myositis Specific Autoantibodies or Other Rashes Leads to Better Sensitivity but Lower Specificity of 2017 EULAR/ACR Myositis Classification Criteria for Dermatomyositis

    Yusra Hasan1, Katharine Ching Chung2, Dana Ascherman3, Siamak Moghadam-Kia4, Chester V. Oddis3 and Rohit Aggarwal3, 1CHI Health Creighton University Medical Center, Omaha, NE, 2University of Pittsburgh Medical Center, Mckeesport, PA, 3University of Pittsburgh, Pittsburgh, PA, 4University of Pittsburgh Medical Center, Pittsburgh, PA

    Background/Purpose: Idiopathic Inflammatory Myopathies (IIM), collectively known as myositis, are heterogeneous disorders characterized by muscle weakness and muscle inflammation. ACR/EULAR classification criterion for IIM was…
  • Abstract Number: 1951 • ACR Convergence 2023

    Valid and Reliable Physical Function Tests in Idiopathic Inflammatory Myositis

    Tanya Chandra1, Raisa Lomanto Silva2, shiri keret3, Akanksha Sharma4, Siamak Moghadam-Kia2, Dana Ascherman5, Chester V. Oddis5 and Rohit Aggarwal5, 1Georgetown University Hospital, Washington, DC, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3Bnai Zion, Atlit, Israel, 4UPMC Mercy Hospital, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) can cause significant impairment in physical function. Sit to Stand (STS) and Timed Up and Go (TUG) are quick and…
  • Abstract Number: 0300 • ACR Convergence 2023

    Nailfold Videocapillaroscopy in Idiopathic Inflammatory Myopathy Compared with Healthy Controls

    Megan Sullivan1, Maximiliano Diaz-Menindez2, Colleen T. Ball2, Benjamin Wang3 and Florentina Berianu1, 1Mayo Clinic Florida, Jacksonville, FL, 2Mayo Clinic Jacksonville, Jacksonville, FL, 3Mayo Clinic, Jacksonville, FL

    Background/Purpose: Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune disorders that cause inflammation of the muscle. This includes dermatomyositis and polymyositis. Literature has been…
  • Abstract Number: 1176 • ACR Convergence 2023

    Brepocitinib Prevents Type-I Interferon Induced Damage in Cultured Myocytes and Endothelial Cells Indicating a Potential Role in the Treatment of Dermatomyositis

    Jiri Vencovsky1, Jolie Feldman2, Lisa McConnachie2 and Brendan M. Johnson2, 1Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 2Priovant Therapeutics, Durham, NC

    Background/Purpose: Dermatomyositis (DM), an idiopathic inflammatory myopathy, is a chronic and often debilitating condition characterized by a hallmark skin rash (e.g., Gottron's sign and heliotrope…
  • Abstract Number: 1952 • ACR Convergence 2023

    Anti-MDA5 Associated Dermatomyositis: Clinical Features and Outcomes in a Predominantly African-American Case Series

    David Wang1, Arezou Khosroshahi2 and Prateek Gandiga2, 1Emory University School of Medicine, Atlanta, GA, 2Emory University, Atlanta, GA

    Background/Purpose: Individuals with autoantibodies against melanoma differentiation-associated protein 5 (MDA-5) are reported to have a significant risk of developing rapidly progressive and fatal interstitial lung…
  • Abstract Number: 028 • 2023 Pediatric Rheumatology Symposium

    Achieving Medication-Free Remission in Juvenile Dermatomyositis

    Harneet Ghumman1, Ilaria Maccora2, Hermine Brunner1, Amy Cassedy3, Mekibib Altaye2, Asra Firdous1, Alexei Grom1, Daniel Lovell1, Angela Merritt1, Megan Quinlan-Waters1 and Sheila Angeles-Han2, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Juvenile dermatomyositis (JDM) is characterized by symmetric proximal muscle weakness, distinct rash, and a risk for calcinosis. Systemic immunosuppression is needed. Evidence is limited…
  • Abstract Number: 064 • 2023 Pediatric Rheumatology Symposium

    Towards the Development of Composite Parent-Centered Disease Activity Scores for Juvenile Dermatomyositis

    Silvia Rosina1, Ana Isabel Rebollo-Giménez2, Letizia Tarantola3, Roberta Naddei4, Alessandro Consolaro2, Angela Pistorio5 and Angelo Ravelli6, 1IRCCS Istituto Giannina Gaslini, Genova, Italy, 2IRCCS Istituto Giannina Gaslini, UOC Reumatologia e Malattie Infiammatorie, Genova, Italy, 3Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI), Genova, Italy, 4Università degli Studi di Napoli Federico II, Dipartimento di Scienze Mediche Traslazionali, Napoli, Italy, 5IRCCS Istituto Giannina Gaslini, Direzione Scientifica, Genova, Italy, 6IRRCS Istituto Giannina Gaslini and Università degli Studi di Genova, Genova, Italy

    Background/Purpose: Increasing attention has been recently paid to the development of parent- and child-centered composite DAS for the assessment of health status of children with…
  • Abstract Number: 066 • 2023 Pediatric Rheumatology Symposium

    Telemedicine Use in the Assessment of Juvenile Myositis: A Mixed-Methods Study of an International Healthcare Provider Experience

    Y. Ingrid Goh1, Peter Blier2, Bianca Lang3, Marietta De Guzman4, Julie Fuller5, Kristin Houghton6, Kathryn Cook7, Susan Kim8, Vanessa Carbone1, Heather Tory9, Jo-Anne Marcuz1, Albert Chow10, Liza McCann11, Charalampia Papadopoulou12, Clarissa Pilkington13 and Stacey Tarvin14, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Retired, Amherst, MA, 3Dalhousie University - Halifax, Halifax, NS, Canada, 4Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 5UT Southwestern, Dallas, TX, 6University of British Columbia, Vancouver, BC, Canada, 7Akron Children's Hospital, Akron, OH, 8UCSF Benioff Children's Hospital, San Francisco, CA, 9Connecticut Children's Medical Center, S Glastonbury, CT, 10Loma Linda University, Loma Linda, CA, 11Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, 12UCL Institute of Child Health, and Great Ormond Street Hospital NHS Foundation Trust, Section Head Infection, Immunology, and Rheumatology, London, United Kingdom, 13Great Ormond Street Hospital, London, United Kingdom, 14Riley Hospital for Children at Indiana University Health, Indianapolis, IN

    Background/Purpose: Care of patients with juvenile myositis (JM) involves complex assessments performed by specialized healthcare providers (HCPs). Restrictions during the COVID-19 pandemic required the rapid…
  • Abstract Number: 070 • 2023 Pediatric Rheumatology Symposium

    The Impact of the COVID-19 Pandemic on Patients with Juvenile Idiopathic Inflammatory Myopathies

    Dawn Wahezi1, Dominique Jerome1, Evin Rothschild1, Jeffrey Dvergsten2, Stacey Tarvin3, Susan Kim4 and Tamar Rubinstein1, 1Children's Hospital at Montefiore, New York, NY, 2Duke University Hospital, Durham, NC, 3Riley Hospital for Children at Indiana University Health, Indianapolis, IN, 4UCSF Benioff Children's Hospital, San Francisco, CA

    Background/Purpose: Since the onset of the COVID-19 pandemic, there have been concerns regarding the risks of SARS-CoV-2 infection in patients with juvenile idiopathic inflammatory myopathies…
  • Abstract Number: 086 • 2023 Pediatric Rheumatology Symposium

    Systemic Sclerosis Overlap Syndrome: A Case Series from a Single Large Pediatric Center

    Jessica Nguyen1, Miriah Gillispie-Taylor1, Eyal Muscal1 and Marietta Deguzman2, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Texas Children's Hospital, Houston, TX

    Background/Purpose: Childhood-onset systemic sclerosis (SSc) is a rare but potentially life-threatening autoimmune condition with features including immune, fibrotic, and vascular manifestations affecting the skin and…
  • Abstract Number: 099 • 2023 Pediatric Rheumatology Symposium

    The Impact of the COVID-19 Pandemic on Juvenile Dermatomyositis

    Tresa Ambooken1, Sangati Kadakia1, Tara Lozy1, Brianna Bulbin2, Suhas Ganguli3, Dawn Wahezi4 and Sivia Lapidus1, 1Department of Pediatrics, Joseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, 2Hackensack Meridian School of Medicine, Hackensack, NJ, 3Department of Pediatrics, K. Hovnanian Children's Hospital, Jersey Shore University Medical Center, Neptune City, NJ, 4Children's Hospital at Montefiore, New York, NY

    Background/Purpose: Juvenile Dermatomyositis (JDM) is theorized to occur in a genetically susceptible individual as a response to an environmental trigger, leading to autoimmunity and inflammation.…
  • Abstract Number: 100 • 2023 Pediatric Rheumatology Symposium

    The Brazilian Registry of Juvenile Dermatomyositis (JDM): II – A Longitudinal Assessment of Muscle Strength by Manual Muscle Test (MMT) and Childhood Myositis Assessment Scale (CMAS) Tools

    Darcisio Antonio1, Taciana Fernandes1, Adriana Elias2, Teresa Robazzi3, Ana Julia Moraes4, Sheila Oliveira5, Flavio Sztajnbok6, Luciana Carvalho7, Luciana Marques8, Silvana Sacchetti9, Maria Teresa Terreri10, Simone Appenzelle11, Roberto Marini12, Carlos Rabello Jr13, Cristina Magalhaes14, Melissa Fraga15, Marcia Bandeira16, Iloite Scheibel17, Isabela Daud2, Beatriz Carneiro2, Claudio Len18, Clovis Silva19 and Claudia Magalhaes20, 1Universidade Estadual Paulista (UNESP) Botucatu, Brazil, 2Instituto da Criança - Universidade de São Paulo (USP), São Paulo, Brazil, 3Universidade Federal da Bahia, Brazil, 4Universidade Federal do Para, Brazil, 5Universidade Federal do Rio de janeiro, Rio de Janeiro, 6Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil, 7Universidade de Sao Paulo- Ribeirao Preto, São Paulo, Brazil, 8Hospital Albert Sabin, Brazil, 9Santa Casa de Sao Paulo, Brazil, 10UNIFESP, São Paulo, Brazil, 11University of Campinas, Campinas, Sao Paulo, Brazil, 12UNICAMP, São Paulo, Brazil, 13Hospital Geral de Fortaleza, Brazil, 14Hospital Jose de Alencar - Brasilia, Brazil, 15Hospital Darcy Vargas, Brazil, 16Hospital Pequeno Principe- Curitiba, Brazil, 17Hospital Conceição de Porto Alegre, Brazil, 18Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 19Universidade de São Paulo, São Paulo, Brazil, 20São Paulo State University, Pediatric Rheumatology Division, Botucatu, Brazil

    Background/Purpose: Muscle weakness is often progressive and persistent in Juvenile Dermatomyositis (JDM). Muscle strength testing is useful for evaluating severity of muscle weakness. There is…
  • Abstract Number: 101 • 2023 Pediatric Rheumatology Symposium

    Differences in Clinical and Patient-reported Outcomes in Juvenile Dermatomyositis by Race and Ethnicity

    Susan Kim1, Rebecca Olveda2 and Jessica Neely2, 1UCSF Benioff Children's Hospital, San Francisco, CA, 2UCSF, San Francisco, CA

    Background/Purpose: Previous studies in juvenile dermatomyositis (JDM) have shown that patients from minoritized ethnicities and those with lower family income are more likely to have…
  • Abstract Number: 120 • 2023 Pediatric Rheumatology Symposium

    The Brazilian Registry of Juvenile Dermatomyositis (JDM): I- Onset Clinical Features and Disease Activity Scores by DAS-20 over 2-Years-Follow Up

    Beatriz Carneiro1, Adriana Elias1, Teresa Robazzi2, Ana Julia Moraes3, Sheila Oliveira4, Flavio Sztajnbok5, Luciana Carvalho6, Luciana Marques7, Silvana Sacchetti8, Maria Teresa Terreri9, Simone Appenzelle10, Roberto Marini11, Andre Cavalcante12, Marcia Bandeira13, Cristina Magalhaes14, Melissa Fraga15, Iloite Scheibel16, Isabela Daud1, Darcisio Antonio17, Claudio Len18, Clovis Silva19, Taciana Fernandes17 and Claudia Magalhaes20, 1Instituto da Criança - Universidade de São Paulo (USP), São Paulo, Brazil, 2Universidade Federal da Bahia, Brazil, 3Universidade Federal do Para, Brazil, 4Universidade Federal do Rio de janeiro, Rio de Janeiro, 5Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil, 6Universidade de Sao Paulo- Ribeirao Preto, São Paulo, Brazil, 7Hospital Albert Sabin, Brazil, 8Santa Casa de Sao Paulo, Brazil, 9UNIFESP, São Paulo, Brazil, 10University of Campinas, Campinas, Sao Paulo, Brazil, 11UNICAMP, São Paulo, Brazil, 12Hospital Materno-Infantil de Goiania, Brazil, 13Hospital Pequeno Principe- Curitiba, Brazil, 14Hospital Jose de Alencar - Brasilia, Brazil, 15Hospital Darcy Vargas, Brazil, 16Hospital Conceição de Porto Alegre, Brazil, 17Universidade Estadual Paulista (UNESP) Botucatu, Brazil, 18Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 19Universidade de São Paulo, São Paulo, Brazil, 20São Paulo State University, Pediatric Rheumatology Division, Botucatu, Brazil

    Background/Purpose: A national registry was set up, enrolling new onset JDM cases in 18 hospitals, during 3-years (2015-2018) with 2-years follow up, in a low…
  • Abstract Number: 004 • 2023 Pediatric Rheumatology Symposium

    Analysis of Patients with Juvenile Dermatomyositis Compared to Healthy Controls Using CITE-seq Identifies Differences in Cell Composition and Gene and Epitope Expression

    Camilla Wibrand1, Emily Flynn2, Gabrielle Rabadam2, George Hartoularos2, Yang Sun2, Chun Ye2, Susan Kim3, Marina Sirota2 and Jessica Neely1, 1UCSF, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3UCSF Benioff Children's Hospital, San Francisco, CA

    Background/Purpose: Juvenile dermatomyositis (JDM) is a rare and serious systemic autoimmune condition, and much remains unknown about the pathogenesis, the immune cell types and cell-specific…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology